CIK 0001574235 · Non-accelerated filer<br>Smaller reporting company
Pulmatrix, Inc.
Sign in to watch- Ticker
- PULM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461821392
- Phone
- (888) 355-4440
- Business address
- 945 CONCORD STREET, SUITE 1217, FRAMINGHAM, MA, 01701
- Former names
- Ruthigen, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-15 | Maki David Director | Grant or award · Stock Option (Right to Buy) | +1,186 | 1,186 | ||
| 2015-06-15 | Hava David L. Chief Scientific Officer | Grant or award | +4,863 | 4,863 | ||
| 2015-06-15 | Hava David L. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +3,555 | 3,555 | ||
| 2015-06-15 | Hava David L. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +804 | 804 | ||
| 2015-06-15 | Hava David L. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +2,668 | 2,668 | ||
| 2015-06-15 | Hava David L. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +2,964 | 2,964 | ||
| 2015-06-15 | Hava David L. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +5,928 | 5,928 | ||
| 2015-06-15 | Hava David L. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +11,855 | 11,855 | ||
| 2015-06-15 | Hava David L. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +13,041 | 13,041 | ||
| 2015-06-15 | Hava David L. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +14,819 | 14,819 | ||
| 2015-06-15 | Clarke Robert W. Chief Executive Officer | Grant or award | +18,667 | 18,667 | ||
| 2015-06-15 | Clarke Robert W. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +7,190 | 7,190 | ||
| 2015-06-15 | Clarke Robert W. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +2,413 | 2,413 | ||
| 2015-06-15 | Clarke Robert W. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +11,855 | 11,855 | ||
| 2015-06-15 | Clarke Robert W. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +23,710 | 23,710 | ||
| 2015-06-15 | Clarke Robert W. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +171,009 | 171,009 | ||
| 2015-06-15 | Clarke Robert W. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +65,626 | 65,625 | ||
| 2015-04-30 | French Gregory M Director | Grant or award · Stock option (right to buy) | +5,000 | 5,000 | ||
| 2015-04-30 | Conley Richard K Director | Grant or award · Stock option (right to buy) | +5,000 | 5,000 | ||
| 2015-04-30 | Akao Akihisa Director | Grant or award · Stock option (right to buy) | +5,000 | 5,000 |
Page 11 of 12 · 229 trades